ARL2 and leukemia: We previously demonstrated that miR-15a-5p decreased apoptosis induced by DNR and/or cytarabine in leukemia by downregulating three pro-apoptotic target genes—PDCD4, ARL2, and BTG2—validating the implication of miR-15a-5p in drug resistance [21].